Navigation Links
Anesiva Accelerates Its Transition to Specialty Pharma Pain Management Company
Date:9/3/2008

ext quarterly financial results conference call.

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "seek," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. Forward- looking statements in this press release include matters that involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to differ materially from results expressed or implied by this press release. Such risk factors include, among others: whether Zingo gains FDA approval in the adult indication, Anesiva's ability to estimate and address customer demand for Zingo, the degree to which Zingo gains market acceptance, potential delays in the commencement and enrollment of Adlea clinical trials and whether the Adlea clinical development program will support FDA approval for the management of acute pain following orthopedic surgeries. Actual results may differ materially from those contained in the forward-looking statements in this press release. Additional information concerning these and other risk factors is contained in Anesiva's annual report on Form 10-K for the year ended December 31, 2007, and its most recent filing on Form 10-Q.


'/>"/>
SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery
2. Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application
3. Anesiva Announces Publication of Phase 3 Zingo(TM) Data in the Journal Pediatrics
4. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
5. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
6. Anesiva Announces Pivotal Phase 3 Trial of Zingo(TM) Meets Primary Endpoint and Significantly Reduces Venous Access Pain in Adults
7. Anesiva Defines Regulatory Pathway for Adlea with FDA
8. Anesiva Initiates Phase 2 Trial with Adlea(TM) for Pain Relief Following Total Hip Replacement Surgery
9. Anesiva Initiates New Phase 2 Trial of Adlea(TM) for Pain Relief Following Knee Replacement Surgery
10. Anesiva Completes Enrollment in Phase 3 Clinical Trial of Zingo(TM) to Treat Pain Associated With Venous Access Procedures in Adults
11. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...THOUSAND OAKS, Calif., Nov. 21 /PRNewswire-FirstCa...at the European Committee for Medicinal,Products ... recommending,marketing authorisation for Nplate(...e CHMP recommends Nplate for adult chronic immune ...ectomised patients who are refractory to,other tr...
(Date:11/21/2008)...CLINTON, N.J., Nov. 21 Ikaria Hold...Private Company of the Year by the New Jersey Tech...rganization that provides business support, networ...echnology companies and their leaders. Ikaria earn...adership and unique product/service provision. , ...
(Date:11/20/2008)...WASHINGTON, Nov. 20 The...& Gender Equity: , , WHAT: World AIDS..., Tuesday, November 25, 2008 , 11:00 a.m. EST...ongly encouraged: https://cc.readytalk.com/r/1xe4...ns outpacing the number of people newly put on tre...
(Date:11/20/2008)... , , , , PHILADELPHIA, Nov. 20 /PRN...) today announced that the United States Food and ...oval for PROMACTA(R) (eltrombopag) for the treatme...mune (idiopathic) thrombocytopenic purpura (ITP) w...roids, immunoglobulins or splenectomy. The approva...
Breaking Medicine Technology:Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 2Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 3Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 4Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 5Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 6Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 7Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union 8Ikaria(R) Named Private Company of the Year by New Jersey Technology Council 2Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Corgenix Signs Technology Licensing Agreement With Japanese Government 4049 1Corgenix Signs Technology Licensing Agreement With Japanese Government 4049 2Do bacterial combinations result in enhanced cytokine production 3F No 21 14573 1Do bacterial combinations result in enhanced cytokine production 3F No 21 14573 2Does stress damage the brain 3F 14568 1Does stress damage the brain 3F 14568 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 1Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 2Safe at Any Age 3A Octogenarians Do As Well as Younger Patients With Interventional Radiology Arterial Procedures 14563 3
...rvard Medical School ,Contributing Editor , ,... per year, breast cancer undoubtedly qualifies as ...ently, efforts to develop early detection methods ...gress. This is particularly true at the molecular...ve translated into new diagnostic tests and target...
...ibuting Editor ,Harvard Medical School ,The...two of the most important classes of fungi in clin...onment, and hospitals are no exception. Perhaps t...a ) and pulmonary hypersensitivity ( Aspergillus )...tions, but by virtue of intact physical barriers a...
Other Medicine Technology:Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 2Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy 3New Assays to Detect Disseminated Fungal Infections 2New Assays to Detect Disseminated Fungal Infections 3
(Date:11/21/2008)...arents and schools need to work together to stop a... Nov. 21 (HealthDay News) -- Behavior that was onc... as bullying. , And as mounting research shows ...tim, mental-health professionals, schools, parents...ays to combat this threatening behavior. , "Bu...
(Date:11/21/2008)...D, Colo., Nov. 21 Heska ...will present at the New York Society of,Security ... Conference on,December 2, 2008 at 1177 Avenue of...sentation is scheduled to begin at 9:35 a.m. Easte...ilable via live webcast and for two weeks,followi...
(Date:11/21/2008)... might one day lead to a novel technique to combat... 21 (HealthDay News) -- Belgian researchers have d...nstead of sugar for food, and this might lead to n..., To survive and proliferate, all cells in the bo... sugar [glucose], a process that requires oxygen. ...
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
Breaking Medicine News(10 mins):Health News:Getting Tough on Bullying 2Health News:Getting Tough on Bullying 3Health News:New Approach Keeps Tumor Cells From Refueling 2Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2
...autopsy studies that women with Alzheimer’s diseas...heir brain tissue than women with a sound mental h...ena Li and colleges at the University of Chicago. ... models have already revealed that deficiency of e...
...ulsive need to shake legs while sitting or lying d...medical fraternity is not aware of it.// The cond...it difficult for patients to sit down comfortably ...ves or even while watching a movie, say experts. N...
...how old they get, never lose their beauty - they m... ~Martin Buxbaum Jacqueline Saburido was a very no... years ago. // A tragic incident that occurred on ... life. She met with a road traffic accident in whi...
...le professional lives often had the same kind of t...ers.// Physicians disciplined by state medical b...istory of unprofessional behavior while in medical...ipline records, says a study in New England Journa...
Other Medicine News:Health News:Lack Of Estrogen In Brain Tissue Of Women Can Lead To Alzheimer's 2Health News:Shaking Legs Syndrome Is Curable 2Health News:The Looming Controversy Surrounding Facial Transplant 2Health News:Bad professional behavior dates back to medical school 2Health News:Bad professional behavior dates back to medical school 3
...versatile means of sectioning fresh or fixed, anim...g blade principle which allows sectioning without ... the alteration of morphology, the destruction of ...nherent in freezing or embedding procedures are th...
...ovides a versatile means of sectioning fresh or fi... vibrating blade principle which allows sectioning...rtifacts, the alteration of morphology, the destru...effect inherent in freezing or embedding procedure...
...provides a versatile means of sectioning fresh or ... a vibrating blade principle which allows sectioni... artifacts, the alteration of morphology, the dest...s effect inherent in freezing or embedding procedu...
Instrument Cover for Vibratome.
Medicine Products: